ATS Medical, Inc. - Financial and Strategic Analysis Review

ATS Medical, Inc. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “ATS Medical, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of ATS Medical, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

ATS Medical, Inc. (ATS) is engaged in the development, manufacturing and marketing of products and services used for cardiac surgeries. The company offers medical devices for the treatment of structural heart disease focusing on heart valve therapy and devices for the surgical treatment of cardiac arrhythmia. Heart valve therapy devices are sub categorized into mechanical and tissue heart valves and heart valve repair products. Additionally, the surgical arrhythmia therapy products consist of cryotherapy products for the ablation of cardiac arrhythmias. ATS operates in the US, Germany, Austria, France and China. The company is headquartered in Minneapolis, Minnesota, the US.

Recent Developments

Aug 27, 2009: ATS Medical Receives FDA Approval For Clinical Trial Of ATS 3f Aortic Bioprosthesis
Oct 13, 2009: ATS Medical Receives CE Mark Approval For The New ATS CryoMaze 10-S Probe
Nov 02, 2009: ATS Medical Reports Net Sales Of $18.8 Million In Q3 2009

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.